NCT02188576View on ClinicalTrials.gov

The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

January 31, 2018

Conditions
Craniosynostosis
Interventions
DRUG

high dose TXA

DRUG

Low dose TXA

Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT02188576 - The Efficacy and Population Pharmacokinetics of Tranexamic Acid for Craniosynostosis Surgery | Biotech Hunter | Biotech Hunter